HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lusine Danielyan Selected Research

mesedin

1/2020α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin.
12/2017Neuroprotective, Neurogenic, and Amyloid Beta Reducing Effect of a Novel Alpha 2-Adrenoblocker, Mesedin, on Astroglia and Neuronal Progenitors upon Hypoxia and Glutamate Exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lusine Danielyan Research Topics

Disease

7Alzheimer Disease (Alzheimer's Disease)
03/2024 - 04/2010
7Hypoxia (Hypoxemia)
12/2017 - 06/2005
6Neurodegenerative Diseases (Neurodegenerative Disease)
03/2021 - 06/2009
3Inflammation (Inflammations)
03/2024 - 04/2010
3Parkinson Disease (Parkinson's Disease)
03/2021 - 10/2013
3Huntington Disease (Huntington's Disease)
03/2021 - 10/2013
2Fibrosis (Cirrhosis)
03/2024 - 01/2020
2Neuroinflammatory Diseases
01/2019 - 12/2017
2Stroke (Strokes)
01/2019 - 10/2013
1Dysbiosis
03/2024
1Disease Progression
03/2024
1Memory Disorders (Memory Loss)
02/2021
1Glioblastoma (Glioblastoma Multiforme)
10/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2020
1Neurologic Manifestations (Neurological Manifestations)
01/2019
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2019
1Hypertension (High Blood Pressure)
01/2019
1Neoplasms (Cancer)
01/2014
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2014
1Seizures (Absence Seizure)
10/2013
1Feeding and Eating Disorders (Eating Disorder)
10/2013
1Obesity
10/2013
1Autism Spectrum Disorder
10/2013
1Substance-Related Disorders (Drug Abuse)
10/2013
1Cognitive Dysfunction
04/2010
1Body Weight (Weight, Body)
04/2010
1Hyperammonemia
01/2009
1Pathologic Processes
01/2009
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
03/2007
1Brain Injuries (Brain Injury)
06/2005

Drug/Important Bio-Agent (IBA)

5Amyloid beta-PeptidesIBA
03/2024 - 12/2017
4ErythropoietinFDA Link
02/2014 - 11/2005
3Angiotensin Receptor AntagonistsIBA
02/2021 - 04/2010
3Endothelins (Endothelin)IBA
02/2014 - 06/2005
2Amyloid (Amyloid Fibrils)IBA
03/2024 - 12/2017
2Adrenergic Receptors (Adrenergic Receptor)IBA
03/2021 - 01/2020
2mesedinIBA
01/2020 - 12/2017
2Losartan (Cozaar)FDA LinkGeneric
01/2019 - 04/2010
2Interleukin-10 (Interleukin 10)IBA
01/2019 - 04/2010
2Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2019 - 09/2007
2Glutamic Acid (Glutamate)FDA Link
12/2017 - 01/2013
2Neuroprotective AgentsIBA
04/2010 - 04/2006
2cyclo(Trp-Asp-Pro-Val-Leu)IBA
11/2005 - 06/2005
1CytokinesIBA
03/2024
1Proteins (Proteins, Gene)FDA Link
03/2024
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
03/2024
1Collagen Type I (Type I Collagen)IBA
03/2024
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2024
1Actins (F Actin)IBA
03/2024
1polyglutamineIBA
03/2021
1Cholinergic Agents (Cholinergics)IBA
02/2021
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1Insulysin (Insulin-Degrading Enzyme)IBA
01/2019
1Neprilysin (Neutral Endopeptidase)IBA
01/2019
1Prealbumin (Transthyretin)IBA
01/2019
1Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2017
1Messenger RNA (mRNA)IBA
02/2014
1Therapeutic UsesIBA
02/2014
1Oxidopamine (6 Hydroxydopamine)IBA
01/2014
1Hormones (Hormone)IBA
10/2013
1Insulin (Novolin)FDA Link
10/2013
1NeuropeptidesIBA
10/2013
1Oxytocin (Pitocin)FDA LinkGeneric
10/2013
1OrexinsIBA
10/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2013
1Angiotensin IIIBA
04/2010
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2010
1Antihypertensive Agents (Antihypertensives)IBA
04/2010
1Glutamine (L-Glutamine)FDA Link
01/2009
1EnzymesIBA
01/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007
1AntigensIBA
03/2007
1Endothelin Receptors (Endothelin Receptor)IBA
04/2006
1Oxygen (Dioxygen)IBA
06/2005

Therapy/Procedure

5Therapeutics
03/2024 - 06/2009
2Intranasal Administration
10/2020 - 01/2019
1Transplantation
10/2020
1Rejuvenation
11/2005